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Evidence increasingly indicates that breast milk
protects against gastrointestinal, respiratory
tract, middle ear infections, asthma, and sud-
den infant death syndrome (SIDS) (Klonoff-
Cohen et al. 1995; Kovar et al. 1984; Oddy
et al. 2003). Several components of human
milk have been postulated to confer this pro-
tective effect (Goldman et al. 1998). Breast-
feeding might provide an immediate line of
defense against infectious agents, which com-
pensates directly for the immaturity of the
newborn’s immune system and lowered ability
to resist infection. Protection might also be
achieved through specific and nonspecific
factors in milk, including bioactive enzymes,
hormones, growth factors, and immunologic
agents that augment and stimulate the devel-
opment of immature host defense. Thus, it is
not clear which of the many components of
this complex, changing biologic ﬂuid account
for the protective effect.
Passive smoking in the same room as the
infant increases the risk for respiratory disease
and SIDS (Gordon et al. 2002), whereas
breast-feeding is protective for SIDS among
nonsmokers, but not smokers, when adjusted
for potential confounders (Klonoff-Cohen et al.
1995), raising the possibility that there are also
immunologic changes in the breast milk.
However, a clear negative effect of nursing by a
smoker mother has not been demonstrated
(Mitchell et al. 1993), and very little is known
of the mechanisms by which smoke might
account for the reduced protective effect of
breast milk (Blizzard et al. 2003; Elliot et al.
2003).
Cigarette smoke is composed of > 5,000
chemicals, including approximately 70 carcino-
gens (Stedman 1968), very few of which have
actually been assayed for immunosuppressive
activity (Ouyang et al. 2000). Conflicting
reports exist regarding the effects of nicotine
on cytokine production, and little is known
about the nature of the immunosuppressive
compounds in cigarette smoke (Ouyang et al.
2000). Nevertheless, the major phenolic com-
ponents of cigarette tar, hydroquinone and
catechol, have been reported to suppress the
production of interleukin-(IL)1β, IL-2, and
interferon-γ (Kalf et al. 1996; Ouyang et al.
2000). Breast-feeding substantially increases
absorption of nicotine compared with only
environmental tobacco smoke when the
mother smokes (Dahlström et al. 1990; Luck
and Nau 1985; Schulte-Hobein et al. 1992).
In smoker mothers, the milk:plasma con-
centration ratio of nicotine is 2.9, whereas
that of the primary metabolite cotinine is 1.2
(Dahlström et al. 1990). Nicotine has received
much attention because it is immunotoxic,
triggering the immune system and altering the
humoral and cellular immunity and the levels
of certain cytokines and their receptors (Sayers
and Drucker 1999; Sopori et al. 1998).
It has only recently been shown that
human milk contains cytokines (Goldman
et al. 1996). Cytokines are small soluble glyco-
proteins that act in an autocrine or paracrine
manner by binding to speciﬁc cellular recep-
tors, operating in networks, and orchestrating
the immune system’s development and func-
tion. Early milk has an abundance of cytokines
at a time when neonatal organ systems are
immature, suggesting that these bioactive
components of milk might be important in
neonatal immunity development. Growth, dif-
ferentiation, and immunoglobulin production
by B-cells were among the ﬁrst activities found
in human milk and attributed to the presence
of cytokines (Bentzen 1994).
IL-1α is one of the two forms, indistin-
guishable in their biologic activities, of IL-1,
the prototypic proinflammatory cytokine,
involved in the mechanisms underlying many
infectious and noninfectious inflammatory
diseases. Although IL-1 can up-regulate host
defenses and function as an immunoadjuvant,
it is a highly proinﬂammatory cytokine. The
margin between clinical beneﬁt and unaccept-
able toxicity in humans is exceedingly narrow.
In contrast, agents that reduce the production
and/or activity of IL-1 are likely to have an
impact on clinical medicine. The synthesis,
processing, secretion, and activity of IL-1 are
tightly regulated events. For instance, the
presence of an IL-1 receptor antagonist is an
important mechanism through which IL-1
signaling is down-regulated, and therefore its
activity is reduced (Dinarello 1998). IL-1 is
probably the first cytokine that has been
quantified in human milk (Munoz et al.
1990). IL-1β, but not IL-1α, was frequently
investigated and found in colostrum and early
milk samples from healthy lactating mothers.
To the best of our knowledge, the effect of
cigarette smoking on the immunologic func-
tion of the mammary gland has not been
studied previously.
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Tobacco smoke is immunotoxic, but the effect of smoking on the immunologic function of the
mammary gland of mothers who smoke cigarettes (“smoker mothers”) has not been studied. Our
objective was to test, in smoker mothers, the colostral and transitional milk concentrations of
interleukin-(IL)1α. The immunomodulators β-endorphin and leptin were also tested. Pregnant
women who self-identiﬁed as smokers (≥ 5 cigarettes per day through pregnancy) or nonsmokers
were recruited for study participation. The study population included 42 smoker and 40 non-
smoker nursing mothers, with otherwise uncomplicated gestation, delivery, and puerperium, who
were breast-feeding ad libitum their healthy neonates. Colostrum was obtained on the third post-
partum day at 0900 hr and transitional milk on the 10th postpartum day at 0900 hr. IL-1α con-
centrations were significantly reduced in the colostrum of smoker mothers compared with
nonsmoker mothers (p < 0.01). Colostral β-endorphin and leptin concentrations were comparable.
No signiﬁcant differences were found between smoker and nonsmoker lactating mothers in transi-
tional milk concentrations of IL-1α, β-endorphin, and leptin. Moreover, β-endorphin and leptin
concentrations were signiﬁcantly reduced in transitional milk samples compared with colostrum
of both smoker and nonsmoker mothers (p < 0.05); also, IL-1α transitional milk concentrations
were reduced compared with colostrum, but without any significance. This analysis shows that
maternal smoking alters the colostral milk levels of the proinflammatory cytokine IL-1α . The
altered postnatal provision of alternative source of the proinflammatory cytokine IL-1α adds
understanding to how breast-feeding could be nonprotective against infections among the
neonates nursed by smoker mothers. Key words: β-endorphin, cigarette smoke, colostrum, inter-
leukin-1α, leptin, maternal smoking, transitional milk. Environ Health Perspect 113:1410–1413
(2005). doi:10.1289/ehp.7702 available via http://dx.doi.org/ [Online 15 June 2005]Our objective was to determine whether
there is a relationship between IL 1-α levels in
milk and smoking habits in nursing mothers,
with the consequent implications on the devel-
opment of the immune system. Other factors in
milk considered for association with infection
risk in infancy were the immunomodulators
β-endorphin and leptin. β-Endorphin was
assessed because it is produced by the epithelial
cells (i.e., the primary cells in human milk)
(Khachaturian et al. 1958), it exists at detectable
levels in human milk (Zanardo et al. 2001), and
it inﬂuences the behavior of other cells and tis-
sues. Leptin, induced by lipopolysaccharide
(LPS) and cytokines, participates in the host
response to inﬂammation by modulating the
host immune and cytokine responses after LPS
(Faggioni et al. 1999). Thus, any effects of a
given cytokine could be tested for speciﬁcity by
comparison with the other immunologically
active components.
Materials and Methods
Longitudinal and cross-sectional human milk
samples were obtained from mothers hospital-
ized in regional tertiary maternity care at Padua
University (Italy), from June to December
2002. Human milk was collected by mothers
via commercial breast pumps, frozen immedi-
ately, and stored. Collection date and time
were recorded, as were infants’ birth date,
gestational age, birth weight, and sex and
mothers’ demographic and anthropometrical
characteristics [age, education, parity, body
mass index (BMI)], diagnoses, pregnancy com-
plications, and route of delivery (cesarean sec-
tion vs. vaginal).
Before the infant’s birth, pregnant women
were asked by experienced research midwives
to participate in a prospective study. The
women received verbal and written informa-
tion about the aim and design of the study.
Only healthy women ≥ 18 years of age, not
taking anti-inflammatory medications at the
time of enrollment, with otherwise uncompli-
cated gestation, delivery, and puerperium and
who planned to obtain care for their new-
borns through rooming-in and exclusively
breast-feeding their newborns were eligible.
Allergy in mothers was not an exclusion crite-
rion because of the findings that maternal
atopy shows no relationship with cytokine
level in milk (Bottcher et al. 2000). After the
women accepted participation, their smoking
history was recorded.
Of the 1,217 eligible participants, 25 of
26 self-identiﬁed as smokers (≥ 5 cigarettes per
day through pregnancy until last trimester)
were recruited for study participation. One
was excluded from the ﬁnal analysis because of
maternal fever. Control participants included
consecutive women without history of smok-
ing and matched a smoking participant on the
basis of overall inclusion criteria. A written
informed consent was obtained from all
participants.
Milk specimen collection and processing.
Breast milk samples were collected during the
third postpartum day (before discharge) and on
the 10th postpartum day, close to expression of
the colostrum and transitional milk production
phases. Collection was standardized to reduce
bias and potential diurnal variability in cytokine
measurements. Specimens were obtained
within 1 hour of the ﬁrst feeding in the morn-
ing, deﬁned as 0800 hr to 0900 hr. Mothers
were asked not to feed for 3 hr before collec-
tion. All mothers were able to provide milk at
each sampling point. An aliquot of 3 mL was
taken using a manual breast pump. Samples
were temporarily stored at –70°C in sterile plas-
tic tubes and used for assays.
Samples were thawed and centrifuged for
10 min at 1800 rpm at 4°C, after which the
lipid layer and cellular elements were removed.
The aqueous fraction was filtered (0.45-µm
Acrodisc; Gelman Sciences, Ann Arbor, MI,
USA) and was used for cytokine, β-endorphin,
and leptin determinations, with the lipid layer
frozen for other studies.
Milk IL1-α, β-endorphin, and leptin
assays. Filtered aqueous milk fractions were
assayed for IL-1α (by CytElisa Human IL-1α
ACCUCYTE; CytImmune Sciences Inc.,
Rockville, MD, USA), β-endorphin (beta-
Endorphin 60 T kit RIA; Nichols Institute
Diagnostic, San Juan Capistrano, CA, USA),
and leptin (ACTIVE Human Leptin IRMA,
DSL-23100; Diagnostic Systems Laboratories
Inc., Webster, TX, USA) levels. All fractions
were assayed undiluted. The coefficients of
variation for intraassay and interassay, respec-
tively, are the following: IL-1α, 8.3 and
11.2%; β-endorphin, 4.1 and 7.1%; and lep-
tin, 3.7 and 6.6%.
Statistical analysis. Unless otherwise speci-
fied, results are expressed as mean concen-
trations in nanograms per liter or micrograms
per liter ± SE. The p = 0.05 signiﬁcance level
was used for the statistical analysis. We grouped
human milk samples into third postpartum day
smoker and nonsmoker mother groups, with
42 and 40 samples per group, respectively, and
into 10th postpartum day smoker and non-
smoker mother groups, with 42 and 40 samples
per group, respectively.
Because the concentrations of cytokine IL-1,
β-endorphin, and leptin were not normally
distributed, we performed a paired analysis
with the Mann-Whitney U-test. We used the
Student t-test for the analysis of the other data.
Ethics. The research protocol was approved
by the Hospital Ethical Committee for
Human Research of the University of Padua.
Results
We analyzed 164 milk samples, collected from
82 mothers, 42 smokers, and 40 nonsmokers.
Measurable immunoreactivity levels were
observed in most colostral (third day) and tran-
sitional (10th day) milk samples throughout
the collection period (> 90%). The smoker
mothers of healthy-term infants and control
nonsmoker mothers of healthy-term infants
who planned to breast-feed their infants were
comparable in their anthropometric charac-
teristics and those of the respective neonates.
The birth weight of the newborn infants of
smoker mothers was not significantly lower
(Table 1).
IL-1α concentrations were significantly
reduced in the colostrum of smoker com-
pared with the nonsmoker control mothers.
β-Endorphin and leptin colostrum concentra-
tions were comparable (Table 2).
Moreover, β-endorphin concentrations
were signiﬁcantly reduced in transitional milk
samples compared with colostrum of both
smoker and nonsmoker mothers. Also, leptin
concentrations were significantly reduced in
transitional milk samples compared with
colostrum of both smoker and nonsmoker
group. IL-1α concentrations were lower in
transitional milk than in colostrum samples of
smoker and nonsmoker mothers, but without
any signiﬁcance (Table 2).
We found no significant differences
between smoker and nonsmoker lactating
mothers in transitional milk concentrations of
IL-1α, β-endorphin, and leptin (Table 2). And
we found no correlations between reduced
IL-1α levels of the colostral milk samples and
related immunomodulator β-endorphin and
leptin levels.
Discussion
In this article, we present novel evidence sug-
gesting that exposure to tobacco smoke dur-
ing pregnancy may affect the development of
the immunologic function of the mammary
gland, signiﬁcantly inﬂuencing colostral milk
provision of the proinflammatory cytokine
IL-1α for breast-feeding infants. By contrast,
the concentration of the immunomodulatory
factors β-endorphin and leptin were unaf-
fected. In this context, the possibility that
delivery modalities, parity, or BMI affects the
levels of cytokines and immunomediators in
the breast milk is open to speculation.
The identiﬁcation of reduced IL-1α levels
in the colostral milk of mothers exposed to
tobacco smoke during pregnancy offers sup-
port to the hypothesis that some clinical con-
sequences of smoking on infancy might be
initiated and enhanced by altered levels of
inflammatory cytokines (Froen et al. 2000;
Sayers and Drucker 1999).
Early breast milk may be of particular
importance in the development of the mam-
malian newborn innate and acquired immu-
nity (Goldman et al. 1998). Colostrum has
been reported to contain a large amount of
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concentrations and associations within breast
milk (Laiho et al. 2003). IL-1 is probably the
first cytokine that has been quantified in
human milk (Garofalo and Goldman 1998;
Munoz et al. 1990). The synthesis, processing,
secretion, and activity of IL-1 are tightly regu-
lated events. For instance, the presence of an
IL-1 receptor antagonist is an important
mechanism through which IL-1 signaling
is down-regulated, and therefore its activity is
reduced (Dinarello 1997). Of interest, IL-1β
receptor antagonists have been measured in
human breast milk (Buescher and Malinowska
1996). To what extent the biologic effect of
the cytokine in milk is modulated by the pres-
ence of soluble receptors and other cytokine
antagonist is open to speculation.
Smoking is a major risk factor for both
infantile infections and SIDS. Such infections,
both viral and bacterial, also increase the SIDS
risk (Gordon et al. 2002; Guntheroth 1989).
In experimental animals, nicotine has been
shown to depress both the primary and sec-
ondary immune response of the lungs, lymph
nodes, and spleen (Sayers and Drucker 1999).
Interestingly, most studies have shown a
decrease in proinflammatory cytokine pro-
duction (IL-1α, IL-6, and tumor necrosis
factor-α) by lung macrophages in smokers,
accounting for the greater concentration of
tobacco in the lungs (Froen et al. 2000; Sayers
and Drucker 1999). These cells have proven
very sensitive to both smoking history and the
duration of the smoke-free period (Zeidel et al.
2002). Similarly, the greater concentration of
tobacco components reported in the breast
milk of smoker mothers could imply a differ-
ent magnitude of immune impairment of the
mammary gland macrophages (Klonoff-Cohen
et al. 1995). The possibility that altered levels
of cytokines and other biologic factors in breast
milk modify the immune function in the
nursed infants is a very attractive hypothesis
(Jones and Warner 2000). Physiologic delays
or imbalance in the production of immune fac-
tors can occur in mammals, and such delays
increase the risk of infection and SIDS (Laiho
et al. 2003).
Human milk is an important source of
other bioactive substances, including hormones,
growth factors, and immunologic factors such
as cytokines, but the functional consequences of
an overexpression or of a down-regulation of
most milk immunomodulatory constituents
in neonates are unknown. In our study, the
levels of β-endorphin and leptin in breast milk
were not related to smoking habits of nursing
mothers. The lack of additive effects and the
dissimilarity in response to tobacco smoke
might indicate that these immunomodulatory
molecules are involved in different pathways.
In this context, it is interesting that nicotine can
cause a release of β-endorphin in various brain
regions, and that cytokines and endotoxin can
cause a release of β-endorphin in different
tissues. Moreover, in mice, leptin, induced by
LPS and cytokines, participates in the host
response to inﬂammation by modulating the
host immune and cytokine responses (Faggioni
et al. 1999).
There are certain limitations in our work.
First, only colostral and transitional milk sam-
ples were collected. It is well established that
milk composition differs with delivery modali-
ties, increasing parturition, throughout the
day, at each feeding, and with time. Generally,
milk proteins that are produced and secreted
in the mammary gland are expected to con-
stitute the largest proportion of protein in
human milk and to have more postpartum
variation than do serum proteins that are pas-
sively transferred into milk (Londerdal and
Atkinson 1995). Having multiple cytokine
and immunomediators measures taken over
time from breast-feeding mothers with a
dose–response relationship between smoking
levels and levels of agents would permit veriﬁ-
cation of the assumption underlying this
analysis. In addition, the selection of IL-1,
of leptin, and of β-endorphin, among the
wide range of immunomodulatory factors pre-
sent in breast milk and interconnecting the
neuroendocrine and immune systems, has
been made in the context of the present study
mainly for convenience and not according to
solid scientiﬁc reasons.
However, the study has several strengths.
Our measure of cytokines in colostrum has
been used in previous studies and is valid.
Furthermore, most of the colostral and tran-
sitional milk samples (> 90%) in the study
contained IL-1α, so this is a large enough
group to be confident of the results and of
measurable presence of IL-1α in the early
milk. Nevertheless, it is premature to know
how the findings will pertain to later infec-
tions, because most children of smoking
mothers do not develop infections in the early
perinatal time.
Conclusion
Our data support the suggestion that some
clinical consequences of smoking might
be initiated and enhanced by the production
of inflammatory cytokines from colostrum.
Reduced colostral IL-1α concentrations pro-
vide additional data to the delineation of the
pathophysiologic mechanism that includes
mammary gland immunologic dysfunction in
the cascade of events that can lead to infec-
tions and SIDS. To our knowledge, this is
the first study on the effects of smoking on
the content of cytokines and immunomedia-
tors in human milk. Prospective studies are
required to thoroughly assess the differences
in the composition of breast milk from moth-
ers with different smoking histories and the
immunologic consequences of this for the
offspring.
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Table 2. IL-1α, β-endorphin, and leptin concentrations in the colostrum and transitional milk of smoker
compared with nonsmoker mothers.
Colostrum Transitional milk
Smokera Nonsmokerb Smokerc Nonsmokerd p-Value
IL-1α (ng/L) 17.2 ± 4.0 38.4 ± 7.4 14.4 ± 5.2 21.7 ± 12.5 a vs. b*
β-Endorphin (ng/L) 353.5 ± 29.1 317.5 ± 27.6 152.8 ± 26.5 127.7 ± 2.3 a vs. c**
b vs. d**
Leptin (µg/L) 1.6 ± 0.3 1.5 ± 0.2 0.7 ± 0.1 0.5 ± 0.1 a vs. c*
b vs. d**
Data are presented as mean ± SE, or p-value from Mann-Whitney U-test.
*p < 0.05; **p < 0.01.
Table 1. Demographics, pregnancy, and birth outcomes characteristics of the study groups.
Characteristic Smokers (n = 42) Nonsmokers (n = 40)
Maternal data
Maternal age (years) 31.1 ± 0.9 31.2 ± 1.1
Maternal smoking (cigarettes/day) 3.2 ± 0.7
Maternal education (years) 10.5 ± 2 10.6 ± 3
Parity [primiparous (%)] 35.1 41.4
BMI (kg/m2) 25.3 ± 4.0 25.7 ± 4.2
Vaginosis (%) 2.3 2
Labor induction (%) 7.1 7.2
Duration of labor (hr) 8.9 ± 4.2 8.6 ± 4.3
Mode of delivery [vaginal (%)] 88 92
Birth data
Gestational age (weeks) 39.0 ± 0.3 40.0 ± 0.3
Birth weight (kg) 3.23 ± 0.14 3.48 ± 0.09
Sex (%male) 44 42
Apgar score
1st min 8.8 ± 0.4 9.2 ± 0.2
5th min 9.5 ± 0.1 9.8 ± 0.1
Data are presented as mean ± SD unless otherwise indicated.Maternal smoking and breast milk interleukin-1α
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